COMPETITION RESPONSE OF PSMA-I&T RADIOLABELED WITH LUTETIUM-177 TO LNCAP, PC-3 AND RWPE-1 CELLS
Introduction/Justification: 177Lu-PSMA-I&T stands out as a promisor radiopharmaceutical for therapy of prostate cancer based on the specific bind of Glu-urea-Lys pharmacophoric group prostate-specific membrane antigen (PSMA), anchored in the epithelial prostate cell membrane, overexpressed in prosta...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2025-05-01
|
| Colección: | Hematology, Transfusion and Cell Therapy |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S2531137925000306 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|